The goal of developing reliable genetic tests to guide lung cancer treatment has taken a step forward. Researchers recently evaluated the ability of five high-risk genetic profiles, or signatures, to predict the likelihood that cancer would recur in patients whose non-small cell lung cancer was caught early and surgically removed.



Recent comments
29 weeks 4 days ago